Weight Watchers International Inc. Stock News

WW International (WW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Investors shouldn't discount the influence of Oprah Winfrey. Weight Watchers' shift to prescribing GLP-1 drugs could pay off.

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the fourth quarter and full year 202

WW International had a fantastic year in 2023, but things are off to a catastrophic start in 2024. Eli Lilly's launch of a new service to offer weight-loss drugs poses a big threat to WeightWatchers.

WW International stock has been hammered as consumers flock to new miracle weight loss drugs from big pharma. Downloads of the company's weight loss app are down less than 50% -- but the company's sto

Short-seller Cedar Grove argues that WeightWatchers can't win in a GLP-1 world. The stock has fallen sharply this year after Eli Lilly announced a new telehealth service.

A prognosticator sounded a warning about the weight loss specialist. He noted that competition is increasing, and traditional dieting methods are declining in popularity.

Powerful healthcare company Eli Lilly introduced a new e-commerce platform that will surely boost sales of its new weight loss drug. Investors fear this will put a real dent in WW International's busi

Eli Lilly stock just announced a new online service for obtaining prescriptions and ordering weight loss drugs. WW stock is reacting negatively to the news.

Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication and WW International Inc. NYSE: WW (WeightWatc

Options bears are blasting WW International (WW) today, with 2,010 puts exchanged so far – double the intraday average volume – compared to just 995 calls. Most active is the January 2024 7.50-str

WeightWatchers launches a new program dedicated to helping people who have jumped on the weight-loss drug bandwagon. The program is called the GLP-1 Program.

Yahoo Finance's Brooke DiPalma breaks down WW International's nutrition program incorporating popular weight loss drugs and how pharmaceutical stocks are responding.

The weight-loss platform is launching a new plan, the WeightWatchers GLP-1 Program, for those who are obese or overweight and taking any of the increasingly popular injectable drugs that help with cur

If you want to follow Oprah Winfrey's latest plan for losing weight, be prepared to do, well, everything.